Cardiovascular risk factors in dialyzed patients;Czynniki ryzyka chorób układu sercowo-naczyniowego u chorych dializowanych

Polskie Archiwum Medycyny Wewnetrznej

Volumn 112, Issue 6, 2004, Pages 1425-1431

  Kobus, Grazyna ^a   Małyszko, Jolanta ^a   Myśliwiec, Michal ^a  

^a Klinika Nefrologii I T

Author keywords

Cardiac diseases; Chronic renal failure; Dialysotherapy; Metabolic disorders

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; FIBRINOGEN; LIPID; LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE; PHOSPHATE; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS PATIENT; HORMONE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PERITONEAL DIALYSIS; PERITONEUM; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 15244358667     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Venkatesan J., Henrich W.L.: Anemia, hypertension and myocardial dysfuction in end-stage renal disease. Semin. Nephrol., 1997, 17, 257.
2. Parfrey P.S., Harriett S.D., Griffith SM. i wsp.: Congestive heart failure in dialysis patients. Prevalence, incidense, prognosis and risk factors, Kidney Int., 1995, 47, 884.
3. Bergstrom J., Lindholm B.: Malnutrition cardiac disease and mortality: an integrated point of view. Am. J. Kidney. Dis., 1998, 32, 834.
4. Avram M.M., Goldmaser O., Burrell D.E. i wsp.: The uremic dyslipidemia: a cross sectional and longitudinal study. Am. J. Kidney Dis., 1992, 20, 324.
5. Culleton B., Parfrey P.S.: Cardiovascular risk in continuous ambulatory peritoneal dialysis patients. Perit. Dial. Int., 1996, 16, 10.
6. Foley R.N., Parfrey P.S., Harnett J.D.: Hypoalbuminemia, cardiac morbidity and mortality in endstage renal disease. J. Am. Soc. Nephrol., 1996, 7, 728.
7. Franz M., Pohanka E., Tribl B. i wsp.: Living on chronic hemodialysis between dryness and fluid over- load. Kidney Int., 1997, 51 (suppl. 59), S39.
8. Stompór T., Sułowicz W.: Wybrane czynniki ryzyka sercowo-naczyniowych u pacjentów leczonych cia̧-gła̧ ambulatoryjna̧ dializa̧ otrzewnowa̧. Nefrol. Dial. Pol., 1998, 2, 77.
9. Sydor A., Sulowicz W.: Hiperhomocysteinemia w niewydolności nerek. Przegl. Lek., 1999, 56, 520.
10. Velasquez M.T., Lew S.Q., von Albenini B. i wsp.: Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients. Clin. Nephrol., 1997, 48, 341.
11. Siamopoulos K.C., Elisaf M.S., Bairaktari H.T. i wsp.: Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis. Perit. Dial. Int., 1995, 15, 342.
12. Beckman J.S., Beckman T.W., Chen J. i wsp.: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA, 1990, 87, 1620.
13. Middlleton R.J., Parfrey P.S., Foley R.N.: Left ventricular hypertrophy in the renal patients. J. Am. Soc. Nephrol., 2001, 12, 1079.
14. London G.M.: Cardiovascular disease in chronic renal failure: pathophysiological aspects. Semin. Dial., 2003, 16, 85.
15. Foley R.N.: Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial., 2003, 16, 111.
16. Block G., Port F.K.: Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial., 2003, 16, 140.
17. Fenton S.S.A., Schaubel D.E., Desmeules D.E. i wsp.: Hemodialysis versus peritoneal dialysis: a comparison of and adjusted mortality rates. Am. J. Kidney Dis., 1997, 30, 334.
18. Foley R.N., Parfrey P.S., Harnett J.D. i wsp.: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J. Am. Soc. Nephrol., 1995, 5, 2024.
19. Mittal S.K., Kowalski E., Trenkle J. i wsp.: Prevalence of hypertension in hemodialysis population. Clin. Nephrol., 1999, 51, 77.